New Jersey Assembly Bill A1617

New Jersey 2026-2027 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26

Caption

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

Impact

If enacted, CJ's Law would significantly alter the landscape of New Jersey's drug regulations by categorizing kratom as a controlled dangerous substance. This designation aligns New Jersey with several other states and countries that have moved to restrict or ban the substance entirely. Governor and lawmakers backing this bill argue that it aims to enhance public safety and reduce the risks associated with kratom use, while critics may view it as an overreach that could affect those using it for pain management, especially among individuals recovering from opioid addiction.

Summary

Assembly Bill A1617, designated as 'CJ's Law', seeks to criminalize the manufacture, possession, and sale of products containing kratom, a substance derived from a Southeast Asian plant known for its psychoactive and opioid-like effects. The bill stipulates that individuals caught with kratom face serious legal repercussions based on the quantity involved, with the most severe penalties applied to those possessing one ounce or more. This law echoes public health concerns raised by the FDA due to the potential for abuse and addiction associated with kratom consumption, which can lead to severe health issues such as respiratory depression and agitation.

Notables

A key aspect of this legislative effort is its foundation on the tragic consequences of kratom use, illustrated by CJ Holowach's story. His unfortunate death highlighted the need for clearer safety protocols and warnings for supplements often perceived as benign. The debate surrounding this bill is not only legal and health-oriented but also revolves around societal perceptions of kratom and the broader discourse regarding drug regulation within a public health framework.

Contention

The introduction of A1617 may face scrutiny regarding its implications on personal freedom and the medical use of kratom. Proponents of the bill will likely argue that harsher regulations could prevent further tragedies related to kratom, referencing individual cases such as that of Christopher James Holowach, whose demise is memorialized in the bill’s namesake. Meanwhile, opponents may challenge the adequacy of existing regulations, urging that rather than outright bans, there should be efforts to educate consumers about safe use and dosage.